GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Taiwan Advanced Nanotech Inc (ROCO:6797) » Definitions » Revenue

Taiwan Advanced Nanotech (ROCO:6797) Revenue : NT$0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Taiwan Advanced Nanotech Revenue?

Taiwan Advanced Nanotech's revenue for the three months ended in Dec. 2023 was NT$0.0 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil. Taiwan Advanced Nanotech's Revenue per Share for the three months ended in Dec. 2023 was NT$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.00.

Warning Sign:

Taiwan Advanced Nanotech Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Taiwan Advanced Nanotech was -81.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -48.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 7 years, Taiwan Advanced Nanotech's highest 3-Year average Revenue per Share Growth Rate was 155.90% per year. The lowest was -48.60% per year. And the median was 126.95% per year.


Taiwan Advanced Nanotech Revenue Historical Data

The historical data trend for Taiwan Advanced Nanotech's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advanced Nanotech Revenue Chart

Taiwan Advanced Nanotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 113.96 1,719.08 1,928.39 1,326.53 245.61

Taiwan Advanced Nanotech Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 761.96 304.49 - - -

Competitive Comparison of Taiwan Advanced Nanotech's Revenue

For the Medical Devices subindustry, Taiwan Advanced Nanotech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Advanced Nanotech's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Advanced Nanotech's Revenue distribution charts can be found below:

* The bar in red indicates where Taiwan Advanced Nanotech's Revenue falls into.



Taiwan Advanced Nanotech Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Advanced Nanotech  (ROCO:6797) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Taiwan Advanced Nanotech Revenue Related Terms

Thank you for viewing the detailed overview of Taiwan Advanced Nanotech's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Advanced Nanotech (ROCO:6797) Business Description

Traded in Other Exchanges
N/A
Address
No. 188, Wenhe Road, 6th Floor, Leshan Lane, Guishan District, Taoyuan City, TWN, 330
Taiwan Advanced Nanotech Inc is engaged in development and manufacturing of various functional nanoparticles and automated nucleic acid extraction machines and trading related businesses. With expertise in automation, buffer optimization and modification of magnetic beads, it focuses on offering customer convenient and practical solutions to advance research, life science and molecular diagnostics. It offers various products to meet the requirements of customers. The company's products include Automated Extraction Instruments; Reagent Kit; Mag Nanoparticles; and Consumables.

Taiwan Advanced Nanotech (ROCO:6797) Headlines

No Headlines